InsiderClue
Insiders · Profile

Brennan Kevin M.

SVP, FINANCE AND ACCOUNTING at Xilio Therapeutics. Filing since 2 Jan 2025. CIK 0001971303

Company
Date
Role
Action
Shares
Amount
Of holding
XLO Xilio Therapeutics, Inc.
2 Jan 2026
SVP, FINANCE AND ACCOUNTING
Sold on a plan
1,826
$1.17K
22.3%
XLO Xilio Therapeutics, Inc.
2 Jan 2025
SVP, FINANCE AND ACCOUNTING
Sold on a plan
1,803
$1.77K
36.1%
2 decisions on file.